Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$35.55 - $43.57 $315,577 - $386,770
8,877 New
8,877 $385,000
Q1 2023

Apr 27, 2023

SELL
$45.29 - $50.76 $915,582 - $1.03 Million
-20,216 Reduced 96.88%
650 $29,000
Q4 2022

Feb 02, 2023

SELL
$41.91 - $50.48 $1.04 Million - $1.25 Million
-24,778 Reduced 54.29%
20,866 $1.04 Million
Q3 2022

Nov 04, 2022

BUY
$40.9 - $50.42 $1.87 Million - $2.3 Million
45,644 New
45,644 $1.88 Million
Q2 2022

Aug 03, 2022

SELL
$42.98 - $49.77 $820,832 - $950,507
-19,098 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$42.23 - $54.3 $128,632 - $165,397
-3,046 Reduced 13.76%
19,098 $935,000
Q4 2021

Feb 23, 2022

BUY
$50.62 - $56.47 $873,954 - $974,954
17,265 Added 353.86%
22,144 $1.23 Million
Q2 2021

Aug 12, 2021

SELL
$46.28 - $52.75 $24,574 - $28,010
-531 Reduced 9.82%
4,879 $236,000
Q1 2021

Apr 26, 2021

BUY
$46.25 - $56.02 $162,568 - $196,910
3,515 Added 185.49%
5,410 $263,000
Q4 2020

Feb 02, 2021

BUY
$46.09 - $54.74 $87,340 - $103,732
1,895 New
1,895 $100,000
Q2 2020

Jul 13, 2020

SELL
$39.49 - $44.36 $675,555 - $758,866
-17,107 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$33.17 - $41.6 $446,435 - $559,894
13,459 Added 368.94%
17,107 $711,000
Q4 2019

Feb 05, 2020

BUY
$25.41 - $43.1 $92,695 - $157,228
3,648 New
3,648 $123,000
Q1 2019

Apr 18, 2019

SELL
$33.78 - $40.68 $54,622 - $65,779
-1,617 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$32.65 - $37.95 $49,530 - $57,570
1,517 Added 1517.0%
1,617 $55,000
Q3 2018

Oct 23, 2018

BUY
$35.99 - $39.39 $3,599 - $3,939
100 New
100 $3,000
Q2 2018

Jul 30, 2018

SELL
$31.23 - $37.47 $29,762 - $35,708
-953 Closed
0 $0
Q1 2018

Apr 26, 2018

SELL
$31.01 - $34.72 $1,829 - $2,048
-59 Reduced 5.83%
953 $30,000
Q4 2017

Jan 10, 2018

BUY
$30.68 - $35.37 $31,048 - $35,794
1,012
1,012 $31,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.24B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.